Sexual Health and Quality of Life Assessment among Ovarian Cancer Patients during Chemotherapy

Lavinia Domenici, Innocenza Palaia, Margherita Giorgini, Valerio Piacentino Piscitelli, Federica Tomao, Claudia Marchetti, Violante Di Donato, Giorgia Perniola, Angela Musella, Marco Monti, Ludovico Muzii, Pierluigi Benedetti Panici

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: During the last decades many successful efforts have been made in order to increase life expectancy in ovarian cancer (OC) patients. However, just a few studies have investigated the impact of OC on quality of life (QoL) and sexual function in OC cases during treatment. Objective: The aim of this study was to evaluate the QoL and sexual function of OC patients during chemotherapy (CT). Patients and Methods: Forty-nine subjects were enrolled and filled in the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-OV28, Female Sexual Function Index (FSFI) and Female Sexual Distress Scale (FSDS) questionnaires. The results were evaluated globally and consequently stratified into several groups: single surgery versus multiple surgeries, age ≤48 years versus >48 years, and first-line CT versus multiple lines of CT. Results: Menopause-related symptoms, body image and attitude toward the disease were significantly worse during first-line CT (p = 0.018, p = 0.029 and p = 0.006, respectively). Sexual outcomes resulted in better scores in younger patients in all questionnaires (FSFI: p = 0.001; FSDS: p = 0.048; specific EORTC QLQ-OV28 items: p = 0.022). Scores concerning body image, attitude toward the disease and CT-associated symptoms resulted worse in patients after the first surgery (p = 0.017, p = 0.002 and p = 0.012, respectively). Conclusion: Our study confirms that OC has a detrimental impact on QoL and intimacy, particularly in younger patients, during the first course of CT and after the first cytoreductive surgery.

Original languageEnglish
Pages (from-to)205-210
Number of pages6
JournalOncology
Volume91
Issue number4
DOIs
Publication statusPublished - Oct 1 2016

Fingerprint

Reproductive Health
Ovarian Neoplasms
Quality of Life
Drug Therapy
Body Image
Menopause
Life Expectancy
Organizations
Therapeutics
Research
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Domenici, L., Palaia, I., Giorgini, M., Piscitelli, V. P., Tomao, F., Marchetti, C., ... Panici, P. B. (2016). Sexual Health and Quality of Life Assessment among Ovarian Cancer Patients during Chemotherapy. Oncology, 91(4), 205-210. https://doi.org/10.1159/000447403

Sexual Health and Quality of Life Assessment among Ovarian Cancer Patients during Chemotherapy. / Domenici, Lavinia; Palaia, Innocenza; Giorgini, Margherita; Piscitelli, Valerio Piacentino; Tomao, Federica; Marchetti, Claudia; Di Donato, Violante; Perniola, Giorgia; Musella, Angela; Monti, Marco; Muzii, Ludovico; Panici, Pierluigi Benedetti.

In: Oncology, Vol. 91, No. 4, 01.10.2016, p. 205-210.

Research output: Contribution to journalArticle

Domenici, L, Palaia, I, Giorgini, M, Piscitelli, VP, Tomao, F, Marchetti, C, Di Donato, V, Perniola, G, Musella, A, Monti, M, Muzii, L & Panici, PB 2016, 'Sexual Health and Quality of Life Assessment among Ovarian Cancer Patients during Chemotherapy', Oncology, vol. 91, no. 4, pp. 205-210. https://doi.org/10.1159/000447403
Domenici L, Palaia I, Giorgini M, Piscitelli VP, Tomao F, Marchetti C et al. Sexual Health and Quality of Life Assessment among Ovarian Cancer Patients during Chemotherapy. Oncology. 2016 Oct 1;91(4):205-210. https://doi.org/10.1159/000447403
Domenici, Lavinia ; Palaia, Innocenza ; Giorgini, Margherita ; Piscitelli, Valerio Piacentino ; Tomao, Federica ; Marchetti, Claudia ; Di Donato, Violante ; Perniola, Giorgia ; Musella, Angela ; Monti, Marco ; Muzii, Ludovico ; Panici, Pierluigi Benedetti. / Sexual Health and Quality of Life Assessment among Ovarian Cancer Patients during Chemotherapy. In: Oncology. 2016 ; Vol. 91, No. 4. pp. 205-210.
@article{9e67a8e325554d849a711e2e00e5bb9b,
title = "Sexual Health and Quality of Life Assessment among Ovarian Cancer Patients during Chemotherapy",
abstract = "Background: During the last decades many successful efforts have been made in order to increase life expectancy in ovarian cancer (OC) patients. However, just a few studies have investigated the impact of OC on quality of life (QoL) and sexual function in OC cases during treatment. Objective: The aim of this study was to evaluate the QoL and sexual function of OC patients during chemotherapy (CT). Patients and Methods: Forty-nine subjects were enrolled and filled in the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-OV28, Female Sexual Function Index (FSFI) and Female Sexual Distress Scale (FSDS) questionnaires. The results were evaluated globally and consequently stratified into several groups: single surgery versus multiple surgeries, age ≤48 years versus >48 years, and first-line CT versus multiple lines of CT. Results: Menopause-related symptoms, body image and attitude toward the disease were significantly worse during first-line CT (p = 0.018, p = 0.029 and p = 0.006, respectively). Sexual outcomes resulted in better scores in younger patients in all questionnaires (FSFI: p = 0.001; FSDS: p = 0.048; specific EORTC QLQ-OV28 items: p = 0.022). Scores concerning body image, attitude toward the disease and CT-associated symptoms resulted worse in patients after the first surgery (p = 0.017, p = 0.002 and p = 0.012, respectively). Conclusion: Our study confirms that OC has a detrimental impact on QoL and intimacy, particularly in younger patients, during the first course of CT and after the first cytoreductive surgery.",
author = "Lavinia Domenici and Innocenza Palaia and Margherita Giorgini and Piscitelli, {Valerio Piacentino} and Federica Tomao and Claudia Marchetti and {Di Donato}, Violante and Giorgia Perniola and Angela Musella and Marco Monti and Ludovico Muzii and Panici, {Pierluigi Benedetti}",
year = "2016",
month = "10",
day = "1",
doi = "10.1159/000447403",
language = "English",
volume = "91",
pages = "205--210",
journal = "Oncology",
issn = "0030-2414",
publisher = "UBM Medica Healthcare Publications",
number = "4",

}

TY - JOUR

T1 - Sexual Health and Quality of Life Assessment among Ovarian Cancer Patients during Chemotherapy

AU - Domenici, Lavinia

AU - Palaia, Innocenza

AU - Giorgini, Margherita

AU - Piscitelli, Valerio Piacentino

AU - Tomao, Federica

AU - Marchetti, Claudia

AU - Di Donato, Violante

AU - Perniola, Giorgia

AU - Musella, Angela

AU - Monti, Marco

AU - Muzii, Ludovico

AU - Panici, Pierluigi Benedetti

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Background: During the last decades many successful efforts have been made in order to increase life expectancy in ovarian cancer (OC) patients. However, just a few studies have investigated the impact of OC on quality of life (QoL) and sexual function in OC cases during treatment. Objective: The aim of this study was to evaluate the QoL and sexual function of OC patients during chemotherapy (CT). Patients and Methods: Forty-nine subjects were enrolled and filled in the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-OV28, Female Sexual Function Index (FSFI) and Female Sexual Distress Scale (FSDS) questionnaires. The results were evaluated globally and consequently stratified into several groups: single surgery versus multiple surgeries, age ≤48 years versus >48 years, and first-line CT versus multiple lines of CT. Results: Menopause-related symptoms, body image and attitude toward the disease were significantly worse during first-line CT (p = 0.018, p = 0.029 and p = 0.006, respectively). Sexual outcomes resulted in better scores in younger patients in all questionnaires (FSFI: p = 0.001; FSDS: p = 0.048; specific EORTC QLQ-OV28 items: p = 0.022). Scores concerning body image, attitude toward the disease and CT-associated symptoms resulted worse in patients after the first surgery (p = 0.017, p = 0.002 and p = 0.012, respectively). Conclusion: Our study confirms that OC has a detrimental impact on QoL and intimacy, particularly in younger patients, during the first course of CT and after the first cytoreductive surgery.

AB - Background: During the last decades many successful efforts have been made in order to increase life expectancy in ovarian cancer (OC) patients. However, just a few studies have investigated the impact of OC on quality of life (QoL) and sexual function in OC cases during treatment. Objective: The aim of this study was to evaluate the QoL and sexual function of OC patients during chemotherapy (CT). Patients and Methods: Forty-nine subjects were enrolled and filled in the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-OV28, Female Sexual Function Index (FSFI) and Female Sexual Distress Scale (FSDS) questionnaires. The results were evaluated globally and consequently stratified into several groups: single surgery versus multiple surgeries, age ≤48 years versus >48 years, and first-line CT versus multiple lines of CT. Results: Menopause-related symptoms, body image and attitude toward the disease were significantly worse during first-line CT (p = 0.018, p = 0.029 and p = 0.006, respectively). Sexual outcomes resulted in better scores in younger patients in all questionnaires (FSFI: p = 0.001; FSDS: p = 0.048; specific EORTC QLQ-OV28 items: p = 0.022). Scores concerning body image, attitude toward the disease and CT-associated symptoms resulted worse in patients after the first surgery (p = 0.017, p = 0.002 and p = 0.012, respectively). Conclusion: Our study confirms that OC has a detrimental impact on QoL and intimacy, particularly in younger patients, during the first course of CT and after the first cytoreductive surgery.

UR - http://www.scopus.com/inward/record.url?scp=84991556227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991556227&partnerID=8YFLogxK

U2 - 10.1159/000447403

DO - 10.1159/000447403

M3 - Article

AN - SCOPUS:84991556227

VL - 91

SP - 205

EP - 210

JO - Oncology

JF - Oncology

SN - 0030-2414

IS - 4

ER -